Kamal Alrabi

Amman, AM, JO 
Amman, AM, JO 

Overview

Kamal Alrabi practices practicing medicine in Amman, Jordan.

His clinical expertise encompasses Hiccups, Intussusception in Children, Classical Hodgkin Lymphoma, and Castleman Disease.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Amman, AM, Jordan
Other Locations
Al Jubayhah, AM, Jordan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Pilot, Randomized, Open-label Trial to Determine the Feasibility, Safety, Efficacy, and Pharmacokinetics of Nebulized HCQ01 for the Treatment of Patients With COVID-19 and Cancer
A Pilot, Randomized, Open-label Trial to Determine the Feasibility, Safety, Efficacy, and Pharmacokinetics of Nebulized HCQ01 for the Treatment of Patients With COVID-19 and Cancer
Enrollment Status: Withdrawn
Publish Date: April 07, 2023
Intervention Type: Drug
Study Drug: HCQ01
Study Phase: Phase 1/Phase 2
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
A Randomized, Multicenter, Multinational, Double-Blind Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of Subjects With Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

13 Total Publications

Multimodality approach for locally advanced lung cancer: when is surgery most beneficial?
Multimodality approach for locally advanced lung cancer: when is surgery most beneficial?
Journal: Journal of cardiothoracic surgery
Published: March 25, 2025

Frequently Asked Questions about Kamal Alrabi

Is Kamal Alrabi a top-rated expert for Hiccups?

MediFind is an objective health platform that identifies experts based on real-world data. Kamal Alrabi is classified as an Experienced expert for Hiccups, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kamal Alrabi participate in research or clinical trials?

Yes. Kamal Alrabi has published 13 articles and abstracts on conditions like Hiccups. You can view a list of Kamal Alrabi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Alrabi's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile